Myeloproliferative disorder with eosinophilia and ETV6–ABL gene rearrangement: Efficacy of second-generation tyrosine kinase inhibitors

Gene Rearrangement ◽

Second Generation ◽

Kinase Inhibitors ◽

Myeloproliferative Disorder

Review for "The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors"

10.1002/hon.2721/v1/review1 ◽

2019 ◽

Author(s):

Mark Heaney

Keyword(s):

Tyrosine Kinase ◽

Second Generation ◽

Kinase Inhibitors ◽

Philadelphia Chromosome ◽

Philadelphia Chromosome Positive

Decision letter for "The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors"

10.1002/hon.2721/v1/decision1 ◽

2019 ◽

Keyword(s):

Tyrosine Kinase ◽

Second Generation ◽

Kinase Inhibitors ◽

Philadelphia Chromosome ◽

Philadelphia Chromosome Positive

Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA)

Annals of Hematology ◽

10.1007/s00277-021-04406-1 ◽

2021 ◽

Author(s):

Massimo Breccia ◽

◽

Simone Celant ◽

Pier Paolo Olimpieri ◽

Odoardo M. Olimpieri ◽

...

Keyword(s):

Mortality Rate ◽

Tyrosine Kinase ◽

Retrospective Analysis ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitors ◽

Chronic Phase

Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

British Journal of Haematology ◽

10.1111/j.1365-2141.2010.08245.x ◽

2010 ◽

Vol 150 (3) ◽

pp. 303-312 ◽

Cited By ~ 24

Author(s):

Fabio P. S. Santos ◽

Hagop Kantarjian ◽

Carmen Fava ◽

Susan O’Brien ◽

Guillermo Garcia-Manero ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Tyrosine Kinase ◽

Myeloid Leukaemia ◽

Second Generation ◽

Kinase Inhibitors ◽

Clinical Impact ◽

Dose Reductions

Chronic Myeloid Leukemia and Second-Generation Tyrosine Kinase Inhibitors: When, How, and Which One?

Seminars in Hematology ◽

10.1053/j.seminhematol.2010.06.002 ◽

2010 ◽

Vol 47 (4) ◽

pp. 344-353 ◽

Cited By ~ 8

Author(s):

Elias Jabbour ◽

Hagop Kantarjian ◽

Jorge Cortes

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitors

Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status

Renal Cell Carcinoma ◽

10.1007/978-1-4939-1622-1_9 ◽

2014 ◽

pp. 207-216

Author(s):

Linda Cerbone ◽

Cora N. Sternberg

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Second Generation ◽

Kinase Inhibitors ◽

Current Status

Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status

International Journal of Hematology ◽

10.1007/s12185-014-1531-0 ◽

2014 ◽

Vol 99 (4) ◽

pp. 513-518 ◽

Cited By ~ 13

Author(s):

Chika Kawajiri ◽

Hiroaki Tanaka ◽

Shinichiro Hashimoto ◽

Yusuke Takeda ◽

Shio Sakai ◽

...

Keyword(s):

Acute Leukemia ◽

Tyrosine Kinase ◽

Successful Treatment ◽

Second Generation ◽

Kinase Inhibitors ◽

Philadelphia Chromosome ◽

Mutation Status ◽

Mixed Phenotype Acute Leukemia ◽

Mixed Phenotype

Application of Second Generation Tyrosine Kinase Inhibitors in BCR-ABL Positive Malignancies in the Post-Transplant Period

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.12.310 ◽

2009 ◽

Vol 15 (2) ◽

pp. 101

Author(s):

E. Klyuchnikov ◽

O. Osanmaz ◽

P. Schafhausen ◽

S. Asenova ◽

T. Zabelina ◽

...

Keyword(s):

Tyrosine Kinase ◽

Second Generation ◽

Kinase Inhibitors ◽

Post Transplant

Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed

Haematologica ◽

10.3324/haematol.2011.049759 ◽

2011 ◽

Vol 96 (12) ◽

pp. 1779-1782 ◽

Cited By ~ 13

Author(s):

A. R. Ibrahim ◽

R. E. Clark ◽

T. L. Holyoake ◽

J. Byrne ◽

P. Shepherd ◽

...

Keyword(s):

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitors ◽

Imatinib Therapy

PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

HemaSphere ◽

10.1097/01.hs9.0000566308.21128.18 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 887-888

Author(s):

T. Toptas ◽

H. Bostan ◽

K. Kut ◽

F. Pepedil Tanrikulu ◽

F. Yilmaz ◽

...

Keyword(s):

Quality Of Life ◽

Tyrosine Kinase ◽

Myeloid Leukemia ◽

Second Generation ◽

Kinase Inhibitors ◽

Symptom Burden ◽

First And Second Generation